Posted by

Understanding Attention Deficit Hyperactivity Disorder (ADHD)
Fred Baughman, MD comments: 

An early diagnosis is a key factor for treatment 
Media Advisory: To contact Laurence Greenhill, M.D., contact Dacia Morris
at (212) 543-5421. On the day of the briefing, call the AMA's Science News
Department at (312) 464-2410.

WASHINGTON-Because many symptoms 

[Fred A. Baughman Jr., MD:
FB: symptoms are subjective. An
objective abnormality is needed, a "sign" or "signs" without which there
is no disease]

 of attention deficit hyperactivity disorder (ADHD)
may be present in normal children at an early age, it should only be
diagnosed after a thorough professional evaluation 

[Fred A. Baughman Jr., MD:
regardless of
the professional doing the evaluation, a physical abnormality = disease is
required, without which a disease = illness- sickness cannot be said to
exist in that patient]

, according to child and adolescent
psychiatrist Laurence Greenhill, M.D.
"ADHD is a behavior and cognitive disorder that begins early in childhood
and affects between five and eight percent of primary school age children,"
said Dr. Greenhill, Ruane Professor, Clinical Child and Adolescent
Psychiatry, Professor, Clinical Psychiatry, Columbia University; Director,
Research Unit on Pediatric Psychopharmacology, New York State Psychiatric
Institute; New York, N.Y. Dr. Greenhill spoke today about his recently
completed research project in preschool children with ADHD at the American
Medical Association's 23rd Annual Science Reporters Conference in
Washington D.C. 

[Fred A. Baughman Jr., MD:
this would be PATS (preschool adhd treatment study)
evaluating Ritalin/amphetamine treatment in children with adhd 3-5 years of

"The kinds of symptoms we look for include trouble paying attention, being
easily distracted, frequently losing things, making careless mistakes or
being impulsive. Kids with ADHD often have problems listening, following
instructions or finishing work. They may often fidget and squirm in class
or leave their seats and run around the room," Dr. Greenhill said.

[Fred A. Baughman Jr., MD:
The "science" reporters to whom he was speaking should have
realized that the criteria of which Dr. Greenhill spoke could apply to any
of their own children; they should have asked, but never do, "Is their an
objective means of making the diagnosis?" as in any real disease.]

"Any of these symptoms by themselves may be perfectly normal," he said.
"What we look for is a collection of symptoms that interferes with the
child's ability to function, either at home, in school or with their
friends. It's important to get an early diagnosis because if ADHD is not
diagnosed until adolescence it can lead to academic failure, low self-esteem,
motor vehicle accidents and an increased risk for substance

[Fred A. Baughman Jr., MD:
suggesting, without doubt, adhd is a disease having the
above prognosis, including SUD, substance abuse disorder.]

"ADHD is a very active area of research 

[Fred A. Baughman Jr., MD:
as if this was evidence it
is a disease, a medical entity]

. In the past 10 years, the
pharmaceutical industry has grown the ADHD medication treatment market from
a several million dollar market to over two billion dollars each year," Dr.
Greenhill said 

[Fred A. Baughman Jr., MD:
this makes it perhaps the biggest health care fraud
in history, but does not a thing to validate it as a disease. Where is the
first case report of ADHD-the disease. There is none]

. "There has
been increasing work on developing new, longer duration treatments that can
be administered once a day by the parent." 

[Fred A. Baughman Jr., MD:
that there are "treatments"
does nothing to validate as a disease.]

According to Dr. Greenhill, the most effective way to treat ADHD is through
a combination of psycho stimulant medications in the context of behaviorally
oriented parent training and behavioral therapy.
"ADHD is a real illness 

[Fred A. Baughman Jr., MD:
no doubt, he is calling it an illness =
sickness= disorder = disease, with no evidence whatsoever of an objective

, but the good news is that it's treatable, even in
children as young as three to five years old," Dr. Greenhill said.
"Treatment often includes medication, but medication alone is rarely an
adequate or ideal intervention. Children almost always do better with a
combination of treatment approaches. Even if the condition is purely

[Fred A. Baughman Jr., MD:
again, no doubt he is pronouncing it "biological" as
in biology gone wrong, biology abnormal, without the least objective
evidence in all of the 24 years of DSM defined ADD and ADHD]

, by
the time most children get help there are secondary issues-self-esteem
issues, school issues and problems in the family. They need help working
these issues through to minimize lasting effects. Further, we now know that
ADHD actually continues into adulthood for as many as half of the children
with the condition." 
Dr. Greenhill concluded, "ADHD is a common and chronic disorder that does not
go away, but our long experience with various medications gives us a very
good sense of how best to use them safely with the best possible outcome for
the patient."

[Fred A. Baughman Jr., MD:
Considering the following, which is not near as helpful as it
wouild be to have his Pharma income, annually in dollars, we have every
right to ask: Is Dr. Greenhill free to pursue science should it lead to
conclusions not favorable to his Pharma employers. What does he make as a
professor compared to annual income from Pharma? To what extent is he paid
for his services, for his opinions by patients, for whom he is supposed to

Today, just as at the launching of the PATS research, there is
not a shred of objective evidence that ADHD is an actual disease. By
process of elimination, it can only be the greatest health care fraud in

Editor's Note: Dr. Greenhill has received grant support from Novartis
Pharmaceutical, Cephalon Pharmaceutical, Eli Lilly & Co., and McNeil. He
has received honoraria from and/or serves on speakers bureaus for Shire
Laboratories, Inc., McNeil Pharmaceutical, Eli Lilly & Co., Janssen
Pharmaceutical, Cephalon Pharmaceutical, and Novartis Pharmaceutical.
Dr. Greenhill has received an honorarium from the American Medical
Association to speak at today's briefing.

Last updated: Oct 08, 2004
Content provided by: AMA Science News

Copyright 1995-2004 American Medical Association. All rights reserved. 

Leave a Reply

  • (will not be published)